Clinical Trials Arena March 27, 2025
The biotech landscape is undergoing rapid transformation, driven by a heightened emphasis on clinical-stage data and increasing demand for clinical trial services and faster deployment. At the same time, increased scrutiny has focused on US policies and regulations, as well as China’s expanding influence in biotech innovation. In this challenging environment we look at emerging market dynamics and what to expect in 2025.
The biotech industry is experiencing an unprecedented transformation, marked by complex market dynamics, shifting global innovation patterns and evolving investment strategies. According to GlobalData’s Pharma Intelligence Center deals database, the biotech sector has also seen a resurgence in venture funding, with private biopharmaceutical venture financing increasing by 20% ($3.8 million) in total deal value from 2023 to...
Today's Sponsors
Today's Sponsor